Wednesday, August 4, 2021

Red Meat | Prevention | Antibiotics, Cancer Information Highlights, 08/04/2021

National Cancer Institute

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

Cancer Information Highlights
From the National Cancer Institute
Updating you about cancer causes, prevention, screening, treatment, coping, and more
 
New from NCI
DNA Damage Links Colorectal Cancer and Diet High in Red Meat
pile of hamburger   Researchers have found a pattern of DNA damage in colorectal tumors that may explain how a diet high in red and processed meat can help cause colorectal cancer.
Advancing Cancer Prevention
Dr. Philip Castle   The director of NCI's Division of Cancer Prevention, Dr. Philip Castle, discusses the division's priority areas and his vision for making more rapid progress in cancer prevention, including the use of precision prevention and immunoprevention.
Can an Antibiotic Treat Cancer?

Researchers have found that an antibiotic discovered in the 1950s, novobiocin, may kill cancer cells that become resistant to PARP inhibitors. Learn more about this research and the clinical trials that are planned.
How Cancer Research Saved Emily's Life
Emily Whitehead and her parents   In 2012, Emily Whitehead was the first child in the world to receive CAR T-cell therapy. Read about her story and the treatment that saved her life.
Approval of Rylaze Will Address Drug Shortage for Childhood ALL

The Food and Drug Administration (FDA) has approved a new form of asparaginase called Rylaze. The drug was developed to help ease shortages of Erwinia asparaginase, a key part of treatment for children and adults with acute lymphoblastic leukemia (ALL).

FDA Approvals
Amivantamab-vmjw

We've added a new drug summary for amivantamab-vmjw (Rybrevant). FDA recently approved this drug to treat adults with non-small cell lung cancer that has spread, has an abnormal EGFR gene, and has worsened during or after platinum chemotherapy.
Pembrolizumab

We've updated our pembrolizumab (Keytruda) drug summary. FDA recently approved pembrolizumab to treat patients with high-risk, early-stage triple-negative breast cancer. FDA also converted pembrolizumab from accelerated approval to full approval to treat people with triple-negative breast cancer that has the PD-L1 protein and has come back and cannot be removed by surgery or has spread.
 
Also of Interest
Hot Flashes and Night Sweats

Hot flashes and night sweats can be caused by cancer or a side effect of treatment. They can occur in both women and men. Learn more about hot flashes and night sweats and ways to treat them.
Coronavirus Vaccines and People with Cancer

Many people being treated for cancer are asking whether they should get a COVID-19 vaccine. On this page, an expert answers questions and responds to concerns about the vaccine.
Contact Us for Help

Information specialists at NCI's Cancer Information Service (CIS), NCI's contact center, are available to help answer your cancer-related questions in English and Spanish. Reach us by phone, chat, or email.

 

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892 GovDelivery logo

Task Force Focuses on Quality of Life for AYAs with Cancer - Cancer Currents Blog

National Cancer Institute

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

You are subscribed to Cancer Currents: An NCI Cancer Research Blog from the National Cancer Institute. Recent posts are listed below.

 

 

08/04/2021
Cancer can greatly disrupt life for adolescents and young adults, who are already going through major life changes. Gathering data on how cancer and its treatment affect this age group will improve their quality of life during and beyond treatment.
This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892 GovDelivery logo

American Heart Association: Eating more plant foods may lower heart disease risk in young adults, older women

Hello HCIS,

Thank you for your interest in news from the American Heart Association. Click below to see the latest updates:

August 04, 2021
Eating more plant foods may lower heart disease risk in young adults, older women

https://newsroom.heart.org/news/eating-more-plant-foods-may-lower-heart-disease-risk-in-young-adults-older-women


Click below to unsubscribe from American Heart Association email alerts.

Unsubscribe

Tuesday, August 3, 2021

Celebrating the 81st anniversary of the ADA!

We’ve accomplished so much—all thanks to you.
View in browser
American Diabetes Association - Connected for Life
August Digital
White Box Left
Helping people thrive for 81 years

Celebrate with us, it’s the 81st anniversary of the American Diabetes Association!

Give today

There’s no better gift to give than your support

Happy 81st anniversary to the American Diabetes Association® (ADA)! The world of diabetes has changed for the better over the last 81 years—the ADA has made sure of it.

Working with and funding world-class researchers, we’ve seen regular advances in diabetes management technology and devices to manage diabetes, breakthroughs in treatment and medications to treat diabetes, and a constant evolution in the understanding of diabetes that will lead us to a cure. Not to mention that our advocacy efforts help protect the rights of people living with diabetes and that our innovative programs help millions understand how to achieve their health goals.

We’ve done so much over the last eight decades thanks to our tremendous supporters. We will continue to drive change and develop and support programs that make a difference. Donate today in honor of the ADA’s anniversary and to invest in our vision of a world free of diabetes and its burdens.
Invest in the ADA

Facebook Twitter Instagram youTube LinkedIn
© 2021 American Diabetes Association®. All rights reserved.

askada@diabetes.org  |   1‑800‑DIABETES

Learn more at diabetes.org.
Forward to a Friend  |   Manage Your Communications  |   Unsubscribe

Reminder: Navigating a Neuroscience Career for Scientists of Color

We're now on Instagram! Follow us @NIMHgov

Navigating a Neuroscience Career for Scientists of Color

Date/Time: Thursday, August 5, 2021, 11:00 a.m. – 12:15 p.m. ET

Location: Virtual

Headshot of Dr. Damien Fair

As a funder and leader in mental health research, NIMH aims to support talented investigators from diverse backgrounds who contribute to transforming our understanding and treatment of mental illnesses. 

This webinar will familiarize the audience with a rising star in neuroscience, Dr. Damien Fair, who has more than a dozen active grants, more than 80 peer-reviewed papers, and nearly two dozen awards and fellowships, including a 2013 Presidential Early Career Award for Scientists and Engineers.

Dr. Fair will describe his academic journey and the traits that have made him one of the most productive and sought-after collaborators in the field of brain imaging.

Register for the webinar


This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Mental Health · 6001 Executive Boulevard · Bethesda, MD 20892-9663 · 1-866-615-6464 GovDelivery logo

The Growing Risks of Not Getting Vaccinated Against COVID-19

Without It, You & Yours are at High Risk for Severe Disease, Hospitalization, and Death

This email was sent to myhcistech.healthnews360@blogger.com by: Military Health System · The Pentagon · Washington, DC 20301 GovDelivery logo